Register entry

Glaxo Wellcome Manufacturing Pte. Ltd

Registered sites
0
Drug products
13
Live patents
0
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Catalogue

Marketed products

13

Showing 13 of 13.

BrandGeneric nameFormCategory
-CabotegravirPOWDERBULK INGREDIENT
-Cabotegravir SodiumPOWDERBULK INGREDIENT
-DaprodustatPOWDERBULK INGREDIENT
-dolutegravir sodiumPOWDERBULK INGREDIENT
-fluticasone furoatePOWDERBULK INGREDIENT
-fluticasone propionatePOWDERBULK INGREDIENT
-lamivudinePOWDERBULK INGREDIENT
-naratriptan hydrochloridePOWDERBULK INGREDIENT
-ondansetronPOWDERBULK INGREDIENT
-salmeterol XinafoatePOWDERBULK INGREDIENT
-trametinibPOWDERBULK INGREDIENT
-umeclidinium bromidePOWDERBULK INGREDIENT
-vilanterol trifenatatePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.